In particular, somatic GOF mutations in JAK1 have been described in oncological pathologies such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and solid-organ cancers [248-250]. This evidence concerns the gene JAK1 and acute lymphoblastic leukemia.